Cash Flow from Operating Activities: A company's cash flows from operations.
Edesa Biotech, Inc. (EDSA) had Cash Flow from Operating Activities of $-7.32M for the most recently reported fiscal year, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.19M |
|
-- |
|
-- |
|
$7.91M |
|
$-7.91M |
|
$0.73M |
|
$-7.18M |
|
$-7.18M |
|
$-7.19M |
|
$-7.19M |
|
$-7.19M |
|
$-7.19M |
|
$-7.91M |
|
$-7.79M |
|
5.68M |
|
5.68M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$11.51M |
|
-- |
|
$2.02M |
|
$13.53M |
|
$1.08M |
|
-- |
|
-- |
|
$1.08M |
|
$3.19M |
|
$10.47M |
|
$12.45M |
|
7.14M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-7.32M |
-- |
|
$17.03M |
|
$1.04M |
|
$10.79M |
|
$9.75M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-225.13% |
|
-68.60% |
|
-53.11% |
|
-57.71% |
|
$1.74 |
|
$-1.29 |
|
$-1.29 |
|